| 臺大學術典藏 |
2021-05-27T08:20:50Z |
Reply to Kim J.S. and Kim B.-W.
|
JYH-MING LIOU; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:50Z |
Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection
|
Chen P.-Y.; Wu M.-S.; Chen C.-Y.; Bair M.-J.; Chou C.-K.; Lin J.-T.; JYH-MING LIOU; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:50Z |
letter: Could sequential therapy extended to 14 days replace prolonged triple regimens for Helicobacter pylori treatment? Authors' reply
|
JYH-MING LIOU; Chen M.-J.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Treatment of Helicobacter pylori infection: Where are we now?
|
JYH-MING LIOU; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
JYH-MING LIOU; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice?
|
JYH-MING LIOU; Lin J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
JYH-MING LIOU; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:48Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.; JYH-MING LIOU; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:48Z |
The Impact of Gastric Atrophy on the Incidence of Diabetes
|
Yu T.-Y.; Wei J.-N.; Kuo C.-H.; JYH-MING LIOU; Lin M.-S.; Shih S.-R.; Hua C.-H.; Hsein Y.-C.; Hsu Y.-W.; Chuang L.-M.; Lee M.-K.; Hsiao C.-H.; Wu M.-S.; Li H.-Y. |
| 臺大學術典藏 |
2021-05-27T08:20:48Z |
Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL
|
Kuo S.-H.; Chen L.-T.; Lin C.-W.; Yeh K.-H.; Shun C.-T.; Tzeng Y.-S.; JYH-MING LIOU; Wu M.-S.; Hsu P.-N.; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-27T08:20:47Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; Wu M.-S.; Chen C.-C.; Chen C.-C.; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; JYH-MING LIOU; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:47Z |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis
|
Kuo Y.-T.; JYH-MING LIOU; El-Omar E.M.; Wu J.-Y.; Leow A.H.R.; Goh K.L.; Das R.; Lu H.; Lin J.-T.; Tu Y.-K.; Yamaoka Y.; Wu M.-S.; for the, Asian Pacific Alliance on Helicobacter; Microbiota |
| 臺大學術典藏 |
2021-05-27T08:20:47Z |
Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale
|
Sheu B.-S.; Wu M.-S.; Chiu C.-T.; Lo J.-C.; Wu D.-C.; JYH-MING LIOU; Wu C.-Y.; Cheng H.-C.; Lee Y.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-27T08:20:47Z |
letter: levofloxacin resistance – a challenge for treatment of Helicobacter pylori infection. Authors' reply
|
Chen P.-Y.; Wu M.-S.; JYH-MING LIOU |
| 臺大學術典藏 |
2021-05-27T08:20:46Z |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis
|
Yeo Y.H.; Shiu S.-I.; Ho H.J.; Zou B.; Lin J.-T.; Wu M.-S.; JYH-MING LIOU; Wu C.-Y. |
| 臺大學術典藏 |
2021-05-27T08:20:46Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; Wu M.-S.; Lin C.-W.; Wei M.-F.; JYH-MING LIOU; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-27T08:20:45Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
JYH-MING LIOU; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; JYH-MING LIOU; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:45Z |
Survey of the adherence to the consensus of gastroesophageal reflux disease before and after the implementation course
|
JYH-MING LIOU; Sheu B.-S.; Lee Y.-C.; Cheng H.-C.; Chang W.-L.; Wu D.-C.; Hsu P.-I.; Wu C.-Y.; Wu M.-S.; Chiu C.-T.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-27T08:20:45Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
JYH-MING LIOU; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:44Z |
Toward population specific and personalized treatment of Helicobacter pylori infection 11 Medical and Health Sciences 1103 Clinical Sciences
|
JYH-MING LIOU; Chen P.-Y.; Kuo Y.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:44Z |
Systematic review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
|
Chen M.-J.; Chen C.-C.; Chen Y.-N.; Chen C.-C.; Fang Y.-J.; Lin J.-T.; Wu M.-S.; JYH-MING LIOU; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:44Z |
The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus
|
Cheng H.-C.; JYH-MING LIOU; Luo J.-C.; Chiu C.-T.; Wu M.-S.; Lee Y.-C.; Wu C.-Y.; Wu D.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T.; Sheu B.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:43Z |
Efficacy and long-term safety of h. Pylori eradication for gastric cancer prevention
|
JYH-MING LIOU; Lee Y.-C.; El-Omar E.M.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:43Z |
From germ theory to germ therapy
|
Chen C.-C.; Chen Y.-N.; JYH-MING LIOU; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:43Z |
Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication
|
Yeo Y.H.; Hsu C.-C.; Lee C.-C.; Ho H.J.; Lin J.-T.; Wu M.-S.; JYH-MING LIOU; Wu C.-Y.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:42Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
JYH-MING LIOU; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:42Z |
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease
|
Lin C.-H.; Chen C.-C.; Chiang H.-L.; JYH-MING LIOU; Chang C.-M.; Lu T.-P.; Chuang E.Y.; Tai Y.-C.; Cheng C.; Lin H.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:41Z |
The interplay between Helicobacter pylori and gastrointestinal microbiota
|
Chen C.-C.; JYH-MING LIOU; Lee Y.-C.; Hong T.-C.; El-Omar E.M.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:41Z |
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study
|
Chiang T.-H.; Chen C.-C.; Tseng P.-H.; JYH-MING LIOU; Wu M.-S.; Shun C.-T.; Lee Y.-C.; Graham D.Y. |
| 臺大學術典藏 |
2021-05-27T08:20:41Z |
Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan
|
Chen M.-J.; Fang Y.-J.; Wu M.-S.; Chen C.-C.; Chen Y.-N.; Yu C.-C.; Kuo C.-C.; Chiu M.-C.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen H.-H.; Bair M.-J.; JYH-MING LIOU; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T02:50:21Z |
Prospective, randomized study of H2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori
|
Lin J.-T.; Wang J.-T.; Wu M.-S.; Lee W.-Y.; JYH-CHIN YANG; Wang T.-H. |
| 臺大學術典藏 |
2021-05-27T02:50:20Z |
Effective reduction of helicobacter pylori infection after upper gastrointestinal endoscopy by mechanical washing of the endoscope
|
Wu M.-S.; Wang J.-T.; JYH-CHIN YANG; Wang H.-H.; Sheu J.-C.; Chen D.-S.; Wang T.-H. |
| 臺大學術典藏 |
2021-05-27T02:50:11Z |
VCP Phosphorylation-Dependent Interaction Partners Prevent Apoptosis in Helicobacter pylori-Infected Gastric Epithelial Cells
|
Yu C.-C.; JYH-CHIN YANG; Chang Y.-C.; Chuang J.-G.; Lin C.-W.; Wu M.-S.; Chow L.-P. |
| 臺大學術典藏 |
2021-05-24T03:41:46Z |
Fluorescent nanodiamonds enable quantitative tracking of human mesenchymal stem cells in miniature pigs
|
Su L.-J.; Wu M.-S.; Hui Y.Y.; Chang B.-M.; Pan L.; Hsu P.-C.; Chen Y.-T.; Ho H.-N.; Huang Y.-H.; Ling T.-Y.; HSAO-HSUN HSU; Chang H.-C. |
| 臺大學術典藏 |
2021-05-24T03:41:41Z |
Intracellular Delivery of Luciferase with Fluorescent Nanodiamonds for Dual-Modality Imaging of Human Stem Cells
|
Su L.-J.;Lin H.-H.;Wu M.-S.;Pan L.;Yadav K.;Hsao-Hsun Hsu;Ling T.-Y.;Chen Y.-T.;Chang H.-C.; Su L.-J.; Lin H.-H.; Wu M.-S.; Pan L.; Yadav K.; HSAO-HSUN HSU; Ling T.-Y.; Chen Y.-T.; Chang H.-C. |
| 臺大學術典藏 |
2021-05-14T05:40:09Z |
Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameter
|
MING-LUN HAN; Lee Y.-C.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Lin T.-L.; Lin L.-W.; Tseng P.-H.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2021-05-14T05:40:08Z |
Use of transnasal endoscopy for screening of esophageal squamous cell carcinoma in high-risk patients: Yield rate, completion rate, and safety
|
Wang C.-H.; Lee Y.-C.; Wang C.-P.; Chen C.-C.; Ko J.-Y.; MING-LUN HAN; Chen T.-C.; Lou P.-J.; Yang T.-L.; Hsiao T.-Y.; Wu M.-S.; Wang H.-P.; Tseng P.-H. |
| 臺大學術典藏 |
2021-05-14T05:40:08Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; MING-LUN HAN; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; Wu M.-S.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-14T05:40:07Z |
Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis
|
MING-LUN HAN; Chen C.-C.; Kuo S.-H.; Hsu W.-F.; Liou J.-M.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2021-05-11T08:15:19Z |
Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis
|
Chang H.-C.;Huang D.-Y.;Wu M.-S.;Chu C.-L.;Shiang-Jong Tzeng;Lin W.-W.; Chang H.-C.; Huang D.-Y.; Wu M.-S.; Chu C.-L.; SHIANG-JONG TZENG; Lin W.-W. |
| 臺大學術典藏 |
2021-05-07T06:47:59Z |
Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer
|
Wei T.-T.; Lin Y.-T.; Chen W.-S.; Luo P.; Lin Y.-C.; Shun C.-T.; Lin Y.-H.; Chen J.-B.; Chen N.-W.; Fang J.-M.; Wu M.-S.; KAI-CHIEN YANG; Chang L.-C.; Tai K.-Y.; Liang J.-T.; Chen C.-C. |
| 臺大學術典藏 |
2021-05-07T06:47:50Z |
Mutual interplay of host immune system and gut microbiota in the immunopathology of atherosclerosis
|
Yeh C.-F.;Chen Y.-H.;Liu S.-F.;Kao H.-L.;Wu M.-S.;Kai-Chien Yang;Wu W.-K.; Yeh C.-F.; Chen Y.-H.; Liu S.-F.; Kao H.-L.; Wu M.-S.; KAI-CHIEN YANG; Wu W.-K. |
| 臺大學術典藏 |
2021-05-07T05:13:42Z |
Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-κB activation
|
Chang Y.J.; Wu M.S.; Lin J.T.; Sheu B.S.; Muta T.; Inoue H.; CHING-CHOW CHEN |
| 臺大學術典藏 |
2021-05-07T05:13:41Z |
Distinct gene expression profiles in gastric epithelial cells induced by different clinical isolates of Helicobacter pylori - Implication of bacteria and host interaction in gastric carcinogenesis
|
Chang Y.-T.; Wu M.-S.; Chang Y.-J.; CHING-CHOW CHEN; Lin Y.-S.; Hsieh T.; Yang P.-C.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-07T05:13:41Z |
Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation
|
Chang Y.-J.; Wu M.-S.; Lin J.-T.; CHING-CHOW CHEN |
| 臺大學術典藏 |
2021-05-07T05:13:40Z |
A novel anticancer effect of thalidomide: Inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-κB
|
Lin Y.-C.; Shun C.-T.; Wu M.-S.; CHING-CHOW CHEN |
| 臺大學術典藏 |
2021-05-07T05:13:40Z |
Mechanisms for Helicobacter pylori CagA-induced cyclin D1 expression that affect cell cycle
|
Chang Y.-J.; Wu M.-S.; Lin J.-T.; Pestell R.G.; Blaser M.J.; CHING-CHOW CHEN |
| 臺大學術典藏 |
2021-05-07T05:13:36Z |
Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies
|
Yang P.-M.; Liu Y.-L.; Lin Y.-C.; Shun C.-T.; Wu M.-S.; CHING-CHOW CHEN |
| 臺大學術典藏 |
2021-05-07T05:13:35Z |
Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma
|
Liu Y.-L.; Yang P.-M.; Shun C.-T.; Wu M.-S.; Weng J.-R.; CHING-CHOW CHEN |
| 臺大學術典藏 |
2021-05-07T05:13:34Z |
HDAC inhibition decreases the expression of EGFR in colorectal cancer cells
|
Chou C.-W.; Wu M.-S.; Huang W.-C.; CHING-CHOW CHEN |
